StockData
Voyager Therapeutics, Inc. logo

Voyager Therapeutics, Inc. (VYGR) stock

VYGRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3058% below fair value
$1.52−0.11 (-6.75%)

Close on Nov 17, 2026Market cap $93.66MP/E –Yield –

Voyager Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Voyager Therapeutics's market cap was $107.84M on Nov 11, 2026, against $226.92M a year earlier. Over the last 5 years it ranged from $102.39M to $499.18M, with a median of $256.22M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$107.84M-50.5%
2025Dec 31, 2025$218.05M-29.5%
2024Dec 31, 2024$309.25M-16.6%
2023Dec 29, 2023$370.59M+57.7%
2022Dec 30, 2022$234.97M+129.5%
2021Dec 31, 2021$102.39M-61.6%
2020Dec 31, 2020$266.43M-48.1%
2019Dec 31, 2019$513.75M+69.2%
2018Dec 31, 2018$303.71M-30.3%
2017Dec 29, 2017$435.76M+34.6%
2016Dec 30, 2016$323.84M+979.6%
2015Dec 31, 2015$30.00M–

More Voyager Therapeutics figures

See a number that looks wrong?